Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILP-C52H5 | Cynomolgus | Cynomolgus IL-1 RAcP / IL-1 R3 Protein, His Tag | ![]() |
![]() ![]() |
|
ILP-M52H5 | Mouse | Mouse IL-1 RAcP / IL-1 R3 Protein, His Tag | ![]() |
![]() ![]() |
|
ILP-H82E5 | Human | Biotinylated Human IL-1 RAcP / IL-1 R3 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
|
ILP-H5256 | Human | Human IL-1 RAcP / IL-1 R3 Protein, Fc Tag | ![]() |
![]() ![]() |
|
ILP-H5225 | Human | Human IL-1 RAcP / IL-1 R3 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
The purity of Human IL-1 RAcP, His Tag (Cat. No. ILP-H5225) is more than 85% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
GSK3903371 | GSK3903371 | Clinical | Glaxosmithkline Plc | Neoplasms | Details |
Nidanilimab | CAN-04 | Phase 2 Clinical | Lund University Foundation | Biliary Tract Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
This web search service is supported by Google Inc.